Zhejiang Garden Bio-chemical High-tech Co Ltd
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cho… Read more
Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) - Total Assets
Latest total assets as of September 2025: CN¥5.91 Billion CNY
Based on the latest financial reports, Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) holds total assets worth CN¥5.91 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Garden Bio-chemical High-tech Co Ltd - Total Assets Trend (2007–2024)
This chart illustrates how Zhejiang Garden Bio-chemical High-tech Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhejiang Garden Bio-chemical High-tech Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang Garden Bio-chemical High-tech Co Ltd's total assets of CN¥5.91 Billion consist of 44.0% current assets and 56.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 22.9% |
| Accounts Receivable | CN¥158.42 Million | 2.8% |
| Inventory | CN¥838.23 Million | 14.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥209.25 Million | 3.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how Zhejiang Garden Bio-chemical High-tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Garden Bio-chemical High-tech Co Ltd's current assets represent 44.0% of total assets in 2024, a decrease from 61.0% in 2007.
- Cash Position: Cash and equivalents constituted 22.9% of total assets in 2024, down from 46.6% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 14.9% of total assets.
Zhejiang Garden Bio-chemical High-tech Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Garden Bio-chemical High-tech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Zhejiang Garden Bio-chemical High-tech Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Zhejiang Garden Bio-chemical High-tech Co Ltd generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Zhejiang Garden Bio-chemical High-tech Co Ltd generates $5.51 in net profit.
Zhejiang Garden Bio-chemical High-tech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 2.14 | 4.38 |
| Quick Ratio | 1.46 | 1.47 | 3.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.32 Billion | CN¥ 1.33 Billion | CN¥ 1.37 Billion |
Zhejiang Garden Bio-chemical High-tech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Garden Bio-chemical High-tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.71 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 6.7% |
| Total Assets | CN¥5.61 Billion |
| Market Capitalization | $736.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Garden Bio-chemical High-tech Co Ltd's assets below their book value (0.13 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Garden Bio-chemical High-tech Co Ltd's assets grew by 6.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Garden Bio-chemical High-tech Co Ltd (2007–2024)
The table below shows the annual total assets of Zhejiang Garden Bio-chemical High-tech Co Ltd from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥5.61 Billion | +6.69% |
| 2023-12-31 | CN¥5.26 Billion | +27.32% |
| 2022-12-31 | CN¥4.13 Billion | +17.21% |
| 2021-12-31 | CN¥3.53 Billion | +2.92% |
| 2020-12-31 | CN¥3.43 Billion | +64.70% |
| 2019-12-31 | CN¥2.08 Billion | +26.32% |
| 2018-12-31 | CN¥1.65 Billion | +18.03% |
| 2017-12-31 | CN¥1.39 Billion | +59.02% |
| 2016-12-31 | CN¥877.15 Million | +11.34% |
| 2015-12-31 | CN¥787.84 Million | +4.32% |
| 2014-12-31 | CN¥755.24 Million | +29.36% |
| 2013-12-31 | CN¥583.85 Million | +7.31% |
| 2012-12-31 | CN¥544.10 Million | +12.20% |
| 2011-12-31 | CN¥484.95 Million | +25.02% |
| 2009-12-31 | CN¥387.88 Million | -14.18% |
| 2008-12-31 | CN¥451.95 Million | -6.74% |
| 2007-12-31 | CN¥484.61 Million | -- |